Home    中文  
 
  • Search
  • lucene Search
  • Citation
  • Fig/Tab
  • Adv Search
Just Accepted  |  Current Issue  |  Archive  |  Featured Articles  |  Most Read  |  Most Download  |  Most Cited

Chinese Journal of Clinicians(Electronic Edition) ›› 2023, Vol. 17 ›› Issue (05): 581-586. doi: 10.3877/cma.j.issn.1674-0785.2023.05.014

• Educational Training • Previous Articles     Next Articles

Development of pediatric clinical pharmacists in drug clinical research: a SWOT analysis

Qian Ding, Qian Wang, Chunyan Guo, Yi Zhang, Yuguang Liang()   

  1. Clinical Research Center, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing 100045, China
  • Received:2023-04-22 Online:2023-05-15 Published:2023-09-08
  • Contact: Yuguang Liang

Abstract:

Objective

To help clinical pharmacists clearly position themselves, seize the opportunity, and actively participate in pediatric clinical research projects.

Methods

Through SWOT analysis, this study analyzed the advantages and disadvantages of clinical pharmacists of Beijing Children's Hospital participating in drug clinical research from four aspects: superiority (S), weak (W), opportunity (O), and threat (T), so as to form development suggestions for pediatric clinical pharmacists in drug clinical research.

Results

Pediatric clinical pharmacists could take advantage of external opportunities to initiate drug clinical studies and participate in drug clinical trials as the principal investigator, and participate in the formulation of clinical research protocols and drug safety incident management as a research team member. Relying on internal advantages, pediatric clinical pharmacists could strengthen popular science education, reduce irrational drug use, and promote clinical research. Seizing the external opportunities, they could improve their professional quality, play a role in drug management for clinical research and drug clinical research quality control to increase clinical research practice experience. Overcoming internal disadvantages, they could play a role in protecting subjects' rights and interests and provide consulting services to improve subjects' compliance.

Conclusion

Pediatric clinical pharmacists should clearly position themselves, seize the opportunity of children's drug research and development, participate in drug clinical research, and provide better pharmaceutical services for children.

Key words: Clinical pharmacist, Pediatric population, SWOT analysis

京ICP 备07035254号-20
Copyright © Chinese Journal of Clinicians(Electronic Edition), All Rights Reserved.
Tel: 010-57830845 E-mail: zhlcyszz@cma.org.cn
Powered by Beijing Magtech Co. Ltd